aluates Reports

$ 0.0

Automative

Global Veterinary Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-23N13648

Global Veterinary Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Veterinary Therapeutics Market Research Report 2025

Code: QYRE-Auto-23N13648

Report

September 2025

Pages:96

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Virbac

Vetoquinol

Zoetis Inc

Elanco

Boehringer Ingelheim

Merck

Ceva

Dechra

Norbrook

Phibro

Huvepharma

Hipra

Ouro Fino Saude

CAHIC

Orion

Ringpu Biology

Nippon Zenyaku Kogyo

Farmavet-Pasteur

Veterinary Therapeutics Market Size

The global market for Veterinary Therapeutics was valued at US$ 26340 million in the year 2024 and is projected to reach a revised size of US$ 38110 million by 2031, growing at a CAGR of 5.5% during the forecast period.

Veterinary Therapeutics Market

Veterinary Therapeutics are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.

North American market for Veterinary Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Veterinary Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Veterinary Therapeutics in Pets is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Veterinary Therapeutics include Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra, Norbrook, Phibro, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Veterinary Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Therapeutics.

The Veterinary Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Veterinary Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Veterinary Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Veterinary Therapeutics Market Report

Report Metric	Details
Report Name	Veterinary Therapeutics Market
Accounted market size in year	US$ 26340 million
Forecasted market size in 2031	US$ 38110 million
CAGR	5.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Anti-Infectives Anti-Inflammatory Parasiticides Analgesics Sedatives Others
Segment by Application	Pets Cattle Poultry Swine Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra, Norbrook, Phibro, Huvepharma, Hipra, Ouro Fino Saude, CAHIC, Orion, Ringpu Biology, Nippon Zenyaku Kogyo, Farmavet-Pasteur
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Veterinary Therapeutics Market growing?

Ans: The Veterinary Therapeutics Market witnessing a CAGR of 5.5% during the forecast period 2025-2031.

What is the Veterinary Therapeutics Market size in 2031?

Ans: The Veterinary Therapeutics Market size in 2031 will be US$ 38110 million.

Who are the main players in the Veterinary Therapeutics Market report?

Ans: The main players in the Veterinary Therapeutics Market are Zoetis, Elanco, Boehringer Ingelheim, Merck, Virbac, Ceva, Vetoquinol, Dechra, Norbrook, Phibro, Huvepharma, Hipra, Ouro Fino Saude, CAHIC, Orion, Ringpu Biology, Nippon Zenyaku Kogyo, Farmavet-Pasteur

What are the Application segmentation covered in the Veterinary Therapeutics Market report?

Ans: The Applications covered in the Veterinary Therapeutics Market report are Pets, Cattle, Poultry, Swine, Others

What are the Type segmentation covered in the Veterinary Therapeutics Market report?

Ans: The Types covered in the Veterinary Therapeutics Market report are Anti-Infectives, Anti-Inflammatory, Parasiticides, Analgesics, Sedatives, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Veterinary Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Anti-Infectives

1.2.3 Anti-Inflammatory

1.2.4 Parasiticides

1.2.5 Analgesics

1.2.6 Sedatives

1.2.7 Others

1.3 Market by Application

1.3.1 Global Veterinary Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Pets

1.3.3 Cattle

1.3.4 Poultry

1.3.5 Swine

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Veterinary Therapeutics Market Perspective (2020-2031)

2.2 Global Veterinary Therapeutics Growth Trends by Region

2.2.1 Global Veterinary Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Veterinary Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Veterinary Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Veterinary Therapeutics Market Dynamics

2.3.1 Veterinary Therapeutics Industry Trends

2.3.2 Veterinary Therapeutics Market Drivers

2.3.3 Veterinary Therapeutics Market Challenges

2.3.4 Veterinary Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Veterinary Therapeutics Players by Revenue

3.1.1 Global Top Veterinary Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Veterinary Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Veterinary Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Veterinary Therapeutics Revenue

3.4 Global Veterinary Therapeutics Market Concentration Ratio

3.4.1 Global Veterinary Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Veterinary Therapeutics Revenue in 2024

3.5 Global Key Players of Veterinary Therapeutics Head office and Area Served

3.6 Global Key Players of Veterinary Therapeutics, Product and Application

3.7 Global Key Players of Veterinary Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Veterinary Therapeutics Breakdown Data by Type

4.1 Global Veterinary Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Veterinary Therapeutics Forecasted Market Size by Type (2026-2031)

5 Veterinary Therapeutics Breakdown Data by Application

5.1 Global Veterinary Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Veterinary Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Veterinary Therapeutics Market Size (2020-2031)

6.2 North America Veterinary Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Veterinary Therapeutics Market Size by Country (2020-2025)

6.4 North America Veterinary Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Veterinary Therapeutics Market Size (2020-2031)

7.2 Europe Veterinary Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Veterinary Therapeutics Market Size by Country (2020-2025)

7.4 Europe Veterinary Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Veterinary Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Veterinary Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Veterinary Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Veterinary Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Veterinary Therapeutics Market Size (2020-2031)

9.2 Latin America Veterinary Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Veterinary Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Veterinary Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Veterinary Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Veterinary Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Veterinary Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Veterinary Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Zoetis

11.1.1 Zoetis Company Details

11.1.2 Zoetis Business Overview

11.1.3 Zoetis Veterinary Therapeutics Introduction

11.1.4 Zoetis Revenue in Veterinary Therapeutics Business (2020-2025)

11.1.5 Zoetis Recent Development

11.2 Elanco

11.2.1 Elanco Company Details

11.2.2 Elanco Business Overview

11.2.3 Elanco Veterinary Therapeutics Introduction

11.2.4 Elanco Revenue in Veterinary Therapeutics Business (2020-2025)

11.2.5 Elanco Recent Development

11.3 Boehringer Ingelheim

11.3.1 Boehringer Ingelheim Company Details

11.3.2 Boehringer Ingelheim Business Overview

11.3.3 Boehringer Ingelheim Veterinary Therapeutics Introduction

11.3.4 Boehringer Ingelheim Revenue in Veterinary Therapeutics Business (2020-2025)

11.3.5 Boehringer Ingelheim Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Veterinary Therapeutics Introduction

11.4.4 Merck Revenue in Veterinary Therapeutics Business (2020-2025)

11.4.5 Merck Recent Development

11.5 Virbac

11.5.1 Virbac Company Details

11.5.2 Virbac Business Overview

11.5.3 Virbac Veterinary Therapeutics Introduction

11.5.4 Virbac Revenue in Veterinary Therapeutics Business (2020-2025)

11.5.5 Virbac Recent Development

11.6 Ceva

11.6.1 Ceva Company Details

11.6.2 Ceva Business Overview

11.6.3 Ceva Veterinary Therapeutics Introduction

11.6.4 Ceva Revenue in Veterinary Therapeutics Business (2020-2025)

11.6.5 Ceva Recent Development

11.7 Vetoquinol

11.7.1 Vetoquinol Company Details

11.7.2 Vetoquinol Business Overview

11.7.3 Vetoquinol Veterinary Therapeutics Introduction

11.7.4 Vetoquinol Revenue in Veterinary Therapeutics Business (2020-2025)

11.7.5 Vetoquinol Recent Development

11.8 Dechra

11.8.1 Dechra Company Details

11.8.2 Dechra Business Overview

11.8.3 Dechra Veterinary Therapeutics Introduction

11.8.4 Dechra Revenue in Veterinary Therapeutics Business (2020-2025)

11.8.5 Dechra Recent Development

11.9 Norbrook

11.9.1 Norbrook Company Details

11.9.2 Norbrook Business Overview

11.9.3 Norbrook Veterinary Therapeutics Introduction

11.9.4 Norbrook Revenue in Veterinary Therapeutics Business (2020-2025)

11.9.5 Norbrook Recent Development

11.10 Phibro

11.10.1 Phibro Company Details

11.10.2 Phibro Business Overview

11.10.3 Phibro Veterinary Therapeutics Introduction

11.10.4 Phibro Revenue in Veterinary Therapeutics Business (2020-2025)

11.10.5 Phibro Recent Development

11.11 Huvepharma

11.11.1 Huvepharma Company Details

11.11.2 Huvepharma Business Overview

11.11.3 Huvepharma Veterinary Therapeutics Introduction

11.11.4 Huvepharma Revenue in Veterinary Therapeutics Business (2020-2025)

11.11.5 Huvepharma Recent Development

11.12 Hipra

11.12.1 Hipra Company Details

11.12.2 Hipra Business Overview

11.12.3 Hipra Veterinary Therapeutics Introduction

11.12.4 Hipra Revenue in Veterinary Therapeutics Business (2020-2025)

11.12.5 Hipra Recent Development

11.13 Ouro Fino Saude

11.13.1 Ouro Fino Saude Company Details

11.13.2 Ouro Fino Saude Business Overview

11.13.3 Ouro Fino Saude Veterinary Therapeutics Introduction

11.13.4 Ouro Fino Saude Revenue in Veterinary Therapeutics Business (2020-2025)

11.13.5 Ouro Fino Saude Recent Development

11.14 CAHIC

11.14.1 CAHIC Company Details

11.14.2 CAHIC Business Overview

11.14.3 CAHIC Veterinary Therapeutics Introduction

11.14.4 CAHIC Revenue in Veterinary Therapeutics Business (2020-2025)

11.14.5 CAHIC Recent Development

11.15 Orion

11.15.1 Orion Company Details

11.15.2 Orion Business Overview

11.15.3 Orion Veterinary Therapeutics Introduction

11.15.4 Orion Revenue in Veterinary Therapeutics Business (2020-2025)

11.15.5 Orion Recent Development

11.16 Ringpu Biology

11.16.1 Ringpu Biology Company Details

11.16.2 Ringpu Biology Business Overview

11.16.3 Ringpu Biology Veterinary Therapeutics Introduction

11.16.4 Ringpu Biology Revenue in Veterinary Therapeutics Business (2020-2025)

11.16.5 Ringpu Biology Recent Development

11.17 Nippon Zenyaku Kogyo

11.17.1 Nippon Zenyaku Kogyo Company Details

11.17.2 Nippon Zenyaku Kogyo Business Overview

11.17.3 Nippon Zenyaku Kogyo Veterinary Therapeutics Introduction

11.17.4 Nippon Zenyaku Kogyo Revenue in Veterinary Therapeutics Business (2020-2025)

11.17.5 Nippon Zenyaku Kogyo Recent Development

11.18 Farmavet-Pasteur

11.18.1 Farmavet-Pasteur Company Details

11.18.2 Farmavet-Pasteur Business Overview

11.18.3 Farmavet-Pasteur Veterinary Therapeutics Introduction

11.18.4 Farmavet-Pasteur Revenue in Veterinary Therapeutics Business (2020-2025)

11.18.5 Farmavet-Pasteur Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Virbac

Vetoquinol

Zoetis Inc

Elanco

Boehringer Ingelheim

Merck

Ceva

Dechra

Norbrook

Phibro

Huvepharma

Hipra

Ouro Fino Saude

CAHIC

Orion

Ringpu Biology

Nippon Zenyaku Kogyo

Farmavet-Pasteur

List of Tables

Table 1. Global Veterinary Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Anti-Infectives

Table 3. Key Players of Anti-Inflammatory

Table 4. Key Players of Parasiticides

Table 5. Key Players of Analgesics

Table 6. Key Players of Sedatives

Table 7. Key Players of Others

Table 8. Global Veterinary Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Veterinary Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Veterinary Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Veterinary Therapeutics Market Share by Region (2020-2025)

Table 12. Global Veterinary Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Veterinary Therapeutics Market Share by Region (2026-2031)

Table 14. Veterinary Therapeutics Market Trends

Table 15. Veterinary Therapeutics Market Drivers

Table 16. Veterinary Therapeutics Market Challenges

Table 17. Veterinary Therapeutics Market Restraints

Table 18. Global Veterinary Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Veterinary Therapeutics Market Share by Players (2020-2025)

Table 20. Global Top Veterinary Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Therapeutics as of 2024)

Table 21. Ranking of Global Top Veterinary Therapeutics Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Veterinary Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Veterinary Therapeutics, Headquarters and Area Served

Table 24. Global Key Players of Veterinary Therapeutics, Product and Application

Table 25. Global Key Players of Veterinary Therapeutics, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Veterinary Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Veterinary Therapeutics Revenue Market Share by Type (2020-2025)

Table 29. Global Veterinary Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Veterinary Therapeutics Revenue Market Share by Type (2026-2031)

Table 31. Global Veterinary Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Veterinary Therapeutics Revenue Market Share by Application (2020-2025)

Table 33. Global Veterinary Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Veterinary Therapeutics Revenue Market Share by Application (2026-2031)

Table 35. North America Veterinary Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Veterinary Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Veterinary Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Veterinary Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Veterinary Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Veterinary Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Veterinary Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Veterinary Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Veterinary Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Veterinary Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Veterinary Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Veterinary Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Veterinary Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Veterinary Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Veterinary Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 50. Zoetis Company Details

Table 51. Zoetis Business Overview

Table 52. Zoetis Veterinary Therapeutics Product

Table 53. Zoetis Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 54. Zoetis Recent Development

Table 55. Elanco Company Details

Table 56. Elanco Business Overview

Table 57. Elanco Veterinary Therapeutics Product

Table 58. Elanco Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 59. Elanco Recent Development

Table 60. Boehringer Ingelheim Company Details

Table 61. Boehringer Ingelheim Business Overview

Table 62. Boehringer Ingelheim Veterinary Therapeutics Product

Table 63. Boehringer Ingelheim Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 64. Boehringer Ingelheim Recent Development

Table 65. Merck Company Details

Table 66. Merck Business Overview

Table 67. Merck Veterinary Therapeutics Product

Table 68. Merck Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 69. Merck Recent Development

Table 70. Virbac Company Details

Table 71. Virbac Business Overview

Table 72. Virbac Veterinary Therapeutics Product

Table 73. Virbac Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 74. Virbac Recent Development

Table 75. Ceva Company Details

Table 76. Ceva Business Overview

Table 77. Ceva Veterinary Therapeutics Product

Table 78. Ceva Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 79. Ceva Recent Development

Table 80. Vetoquinol Company Details

Table 81. Vetoquinol Business Overview

Table 82. Vetoquinol Veterinary Therapeutics Product

Table 83. Vetoquinol Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 84. Vetoquinol Recent Development

Table 85. Dechra Company Details

Table 86. Dechra Business Overview

Table 87. Dechra Veterinary Therapeutics Product

Table 88. Dechra Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 89. Dechra Recent Development

Table 90. Norbrook Company Details

Table 91. Norbrook Business Overview

Table 92. Norbrook Veterinary Therapeutics Product

Table 93. Norbrook Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 94. Norbrook Recent Development

Table 95. Phibro Company Details

Table 96. Phibro Business Overview

Table 97. Phibro Veterinary Therapeutics Product

Table 98. Phibro Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 99. Phibro Recent Development

Table 100. Huvepharma Company Details

Table 101. Huvepharma Business Overview

Table 102. Huvepharma Veterinary Therapeutics Product

Table 103. Huvepharma Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 104. Huvepharma Recent Development

Table 105. Hipra Company Details

Table 106. Hipra Business Overview

Table 107. Hipra Veterinary Therapeutics Product

Table 108. Hipra Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 109. Hipra Recent Development

Table 110. Ouro Fino Saude Company Details

Table 111. Ouro Fino Saude Business Overview

Table 112. Ouro Fino Saude Veterinary Therapeutics Product

Table 113. Ouro Fino Saude Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 114. Ouro Fino Saude Recent Development

Table 115. CAHIC Company Details

Table 116. CAHIC Business Overview

Table 117. CAHIC Veterinary Therapeutics Product

Table 118. CAHIC Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 119. CAHIC Recent Development

Table 120. Orion Company Details

Table 121. Orion Business Overview

Table 122. Orion Veterinary Therapeutics Product

Table 123. Orion Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 124. Orion Recent Development

Table 125. Ringpu Biology Company Details

Table 126. Ringpu Biology Business Overview

Table 127. Ringpu Biology Veterinary Therapeutics Product

Table 128. Ringpu Biology Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 129. Ringpu Biology Recent Development

Table 130. Nippon Zenyaku Kogyo Company Details

Table 131. Nippon Zenyaku Kogyo Business Overview

Table 132. Nippon Zenyaku Kogyo Veterinary Therapeutics Product

Table 133. Nippon Zenyaku Kogyo Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 134. Nippon Zenyaku Kogyo Recent Development

Table 135. Farmavet-Pasteur Company Details

Table 136. Farmavet-Pasteur Business Overview

Table 137. Farmavet-Pasteur Veterinary Therapeutics Product

Table 138. Farmavet-Pasteur Revenue in Veterinary Therapeutics Business (2020-2025) & (US$ Million)

Table 139. Farmavet-Pasteur Recent Development

Table 140. Research Programs/Design for This Report

Table 141. Key Data Information from Secondary Sources

Table 142. Key Data Information from Primary Sources

Table 143. Authors List of This Report

List of Figures

Figure 1. Veterinary Therapeutics Picture

Figure 2. Global Veterinary Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Veterinary Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Anti-Infectives Features

Figure 5. Anti-Inflammatory Features

Figure 6. Parasiticides Features

Figure 7. Analgesics Features

Figure 8. Sedatives Features

Figure 9. Others Features

Figure 10. Global Veterinary Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Veterinary Therapeutics Market Share by Application: 2024 VS 2031

Figure 12. Pets Case Studies

Figure 13. Cattle Case Studies

Figure 14. Poultry Case Studies

Figure 15. Swine Case Studies

Figure 16. Others Case Studies

Figure 17. Veterinary Therapeutics Report Years Considered

Figure 18. Global Veterinary Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 19. Global Veterinary Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 20. Global Veterinary Therapeutics Market Share by Region: 2024 VS 2031

Figure 21. Global Veterinary Therapeutics Market Share by Players in 2024

Figure 22. Global Top Veterinary Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Veterinary Therapeutics as of 2024)

Figure 23. The Top 10 and 5 Players Market Share by Veterinary Therapeutics Revenue in 2024

Figure 24. North America Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. North America Veterinary Therapeutics Market Share by Country (2020-2031)

Figure 26. United States Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Canada Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Europe Veterinary Therapeutics Market Share by Country (2020-2031)

Figure 30. Germany Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. France Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. U.K. Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Italy Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Russia Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Nordic Countries Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Asia-Pacific Veterinary Therapeutics Market Share by Region (2020-2031)

Figure 38. China Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Japan Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. South Korea Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Southeast Asia Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. India Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Australia Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Latin America Veterinary Therapeutics Market Share by Country (2020-2031)

Figure 46. Mexico Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Brazil Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Middle East & Africa Veterinary Therapeutics Market Share by Country (2020-2031)

Figure 50. Turkey Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Saudi Arabia Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. UAE Veterinary Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Zoetis Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 54. Elanco Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 55. Boehringer Ingelheim Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 56. Merck Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 57. Virbac Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 58. Ceva Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 59. Vetoquinol Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 60. Dechra Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 61. Norbrook Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 62. Phibro Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 63. Huvepharma Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 64. Hipra Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 65. Ouro Fino Saude Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 66. CAHIC Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 67. Orion Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 68. Ringpu Biology Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 69. Nippon Zenyaku Kogyo Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 70. Farmavet-Pasteur Revenue Growth Rate in Veterinary Therapeutics Business (2020-2025)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Veterinary Drug Market Research Report 2024

Animal Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Infectious Diseases Therapeutics Market Insights Forecast to 2030

Veterinary Products for Livestock Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pet Veterinary Drug Market Insights Forecast to 2030

Veterinary Antibiotic Treatment Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Equine Veterinary Therapeutics Market Research Report 2024

Global Veterinary Drugs for Companion Animals Market Research Report 2025

Global Veterinary Therapeutic Diet Market Research Report 2024

Veterinary Pharmaceutical Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Care Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Healthcare Product Market Insights Forecast to 2030

Global Veterinary Health Products Market Research Report 2024

Veterinary Syringes and Needles Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Drug and Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Animal Health Care Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Supplements Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions